Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check6 days agoChange DetectedThe study page now displays a 403 Forbidden error with minimal navigation (e.g., Home) and a Revision notice, replacing the previously visible study details and documents.SummaryDifference19%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows an update from revision v3.6.5 to v3.6.6, reflecting a site maintenance/version bump. This does not change the study information or how the NCT03907878 trial is presented.SummaryDifference0.1%

- Check48 days agoChange DetectedThe footer revision tag was updated to v3.6.5, indicating a minor release of the page's documentation. This does not modify the study details or participant information.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating the page has been updated to a newer revision.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor version update to the page's documentation. This reflects editorial or system-level refinements rather than changes to study information.SummaryDifference0.0%

- Check91 days agoChange DetectedThe footer now displays Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a minor revision update behind the page without altering study content.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.